Moleculin Biotech logo

Moleculin Biotech Share Price (NASDAQ: MBRX)

$0.57

0.02

(3.64%)

Live

Last updated on

Check the interactive Moleculin Biotech Stock chart to analyse performance

Moleculin Biotech stock performance

as on August 27, 2025 at 11:50 pm IST

  • Today's Low:$0.49
    Today's High:$0.58

    Day's Volatility :15.46%

  • 52 Weeks Low:$0.25
    52 Weeks High:$3.65

    52 Weeks Volatility :93.15%

Moleculin Biotech Stock Returns

PeriodMoleculin Biotech, Inc.Sector (Health Care)Index (Russel 2000)
3 Months
-38.77%
3.7%
0.0%
6 Months
-56.65%
-6.9%
0.0%
1 Year
-77.89%
-11.9%
0.0%
3 Years
-97.54%
7.7%
-6.9%

Moleculin Biotech, Inc. Key Stats

Check Moleculin Biotech key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$0.55
Open
$0.5684
Today's High
$0.5846
Today's Low
$0.4942
Market Capitalization
$17.4M
Today's Volume
$886.5K
52 Week High
$3.6499
52 Week Low
$0.25
Revenue TTM
$0.0
EBITDA
$-25.3M
Earnings Per Share (EPS)
$-3.74
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-503.8%

Stock Returns calculator for Moleculin Biotech Stock including INR - Dollar returns

The Moleculin Biotech stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Moleculin Biotech investment value today

Current value as on today

₹27,750

Returns

₹72,250

(-72.25%)

Returns from Moleculin Biotech Stock

₹76,923 (-76.92%)

Dollar Returns*

₹4,673 (+4.67%)

Indian investors sentiment towards Moleculin Biotech Stock

-83%

Period: Jul 27, 2025 to Aug 26, 2025. Change in 30 Days versus previous period

Search interest for Moleculin Biotech Stock from India on INDmoney has decreased by -83% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Moleculin Biotech, Inc.

  • Name

    Holdings %

  • Citigroup Inc

    0.28%

  • XTX Topco Ltd

    0.25%

  • Cetera Investment Advisers

    0.23%

  • LPL Financial Corp

    0.15%

  • VERUS CAPITAL PARTNERS, LLC

    0.14%

  • Vanguard Group Inc

    0.10%

Analyst Recommendation on Moleculin Biotech Stock

Rating
Trend

Buy

    88%Buy

    11%Hold

    0%Sell

Based on 9 Wall street analysts offering stock ratings for Moleculin Biotech(by analysts ranked 0 to 5 stars)

Moleculin Biotech Share Price Target

What analysts predicted

Upside of 1128.07%

Target:

$7.00

Current:

$0.57

Moleculin Biotech share price target is $7.00, a slight Upside of 1128.07% compared to current price of $0.57 as per analysts' prediction.

Moleculin Biotech Stock Insights

  • Price Movement

    In the last 7 days, MBRX stock has moved down by -2.6%
  • MBRX vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 61.0% return, outperforming this stock by 138.9%
  • MBRX vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 113.9% return, outperforming this stock by 211.4%

Moleculin Biotech Technicals Summary

Sell

Neutral

Buy

Moleculin Biotech is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Moleculin Biotech, Inc. Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Moleculin Biotech, Inc. logo
-0.75%
-56.65%
-77.89%
-97.54%
-99.32%
Regeneron Pharmaceuticals, Inc. logo
5.16%
-16.9%
-51.12%
-0.89%
-2.51%
Beone Medicines Ltd logo
4.54%
18.87%
52.28%
84.02%
26.72%
Vertex Pharmaceuticals Incorporated logo
-16.02%
-19.22%
-19.42%
37.43%
43.36%
Alnylam Pharmaceuticals, Inc. logo
38.9%
84.99%
60.96%
115.82%
243.29%

About Moleculin Biotech, Inc.

Moleculin Biotech, Inc., a late-stage pharmaceutical development company, engages in the development of therapeutic candidates for the treatment of tumors and viruses. Its lead drug candidate is Annamycin, an anthracycline, which is in clinical stage for the treatment of relapsed or refractory acute myeloid leukemia and soft tissue sarcoma lung metastases. The company is also developing WP1066 portfolio, including WP1066, WP1193, and WP1220, which are immune/transcription modulators designed to inhibit phosphorylated signal transducer and activator of transcription for brain tumors and pancreatic and other cancers. In addition, it is developing WP1122 portfolio, such as WP1122, WP1096, and WP1097 designed to exploit the uses of inhibitors of glycolysis comprising 2-deoxy-D-glucose for the treatment of pathogenic viruses and various cancers. The company was incorporated in 2015 and is headquartered in Houston, Texas.
Organization
Moleculin Biotech
Employees
17
CEO
Mr. Walter V. Klemp
Industry
Health Technology

Key Management of Moleculin Biotech, Inc.

NameTitle
Mr. Walter V. Klemp
Co-Founder, Chairman, President & CEO
Mr. Jonathan P. Foster CPA
Executive VP & CFO
Dr. Donald H. Picker Ph.D.
Chief Scientific Officer
Dr. Waldemar Priebe Ph.D.
Co-Founder, Founding Scientist & Chairman of Scientific Advisory Board
Dr. John Paul Waymack M.D., Sc.D.
Senior Chief Medical Officer

Important FAQs about investing in MBRX Stock from India :

What is Moleculin Biotech share price today?

Moleculin Biotech share price today is $0.57 as on . Moleculin Biotech share today touched a day high of $0.58 and a low of $0.49.

What is the 52 week high and 52 week low for Moleculin Biotech share?

Moleculin Biotech share touched a 52 week high of $3.65 and a 52 week low of $0.25. Moleculin Biotech stock price today i.e. is trending at $0.57, lower by 84.38% versus the 52 week high.

How to invest in Moleculin Biotech Stock (MBRX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Moleculin Biotech on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Moleculin Biotech Shares that will get you 2.6316 shares as per Moleculin Biotech share price of $0.57 per share as on August 27, 2025 at 11:50 pm IST.

What is the minimum amount required to buy Moleculin Biotech Stock (MBRX) from India?

Indian investors can start investing in Moleculin Biotech (MBRX) shares with as little as ₹87.86 or $1 (as of August 27, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹878.60 in Moleculin Biotech stock (as per the Rupee-Dollar exchange rate as on August 27, 2025). Based on Moleculin Biotech share’s latest price of $0.57 as on August 27, 2025 at 11:50 pm IST, you will get 17.5439 shares of Moleculin Biotech. Learn more about fractional shares .

What are the returns that Moleculin Biotech has given to Indian investors in the last 5 years?

Moleculin Biotech stock has given -99.32% share price returns and 18.89% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?